AVITA Medical (RCEL) Share-based Compensation (2018 - 2026)
AVITA Medical's (RCEL) quarterly Share-based Compensation came in at $1.4 million in Q4 2025, down 50.93% YoY from $2.8 million in Q4 2024, and down 50.66% on a QoQ basis from $2.8 million in Q3 2025.
AVITA Medical (RCEL) Share-based Compensation (2018 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 8 years of Share-based Compensation data on file, last reported at $1.4 million in Q4 2025.
- Quarterly Share-based Compensation fell 50.93% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.5 million (down 29.47% YoY) and the FY2025 annual result came in at $9.5 million, down 29.47% from the prior year.
- Share-based Compensation slipped to $1.4 million in Q4 2025, from $2.8 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $4.6 million in Q3 2021 to a low of $1.1 million in Q2 2023.
- A 5-year average of $2.6 million and a median of $2.7 million in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation plunged 68.68% — and 2024, when it surged 252.32%.
- Tracing RCEL's Share-based Compensation over 5 years: stood at $4.6 million in 2021, then tumbled by 45.39% to $2.5 million in 2022, then dropped by 13.3% to $2.2 million in 2023, then advanced by 28.88% to $2.8 million in 2024, then plunged by 50.93% to $1.4 million in 2025.
- The last three Share-based Compensation figures came in at $1.4 million (Q4 2025), $2.8 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.59 Bn | 193.99 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 126.90 Bn | 123.42 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.28 Bn | 109.06 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.95 Bn | 72.41 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.59 Bn | 47.34 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.64 Bn | 31.53 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.08 Bn | 22.76 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | AVITA Medical | 314.42 Mn | 303.28 Mn | 17.77 Mn | 1.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.99 Mn |
| Jun 30, 2026 | 1.99 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 2.78 Mn |
| Sep 30, 2025 | 2.78 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Jun 30, 2024 | 4.03 Mn |
| Jun 30, 2024 | 4.03 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 2.17 Mn |
| Dec 31, 2023 | 2.17 Mn |